Sofia Ramiro

Join Dr Sofia Ramiro, Prof. Rieke Alten & Assoc. Prof. Laura Coates as they discuss key sessions at EULAR 2024. Topics include baricitinib dosages for RA, effectiveness of different medications for RA & PsA, trials on spondyloarthritis medications, and safety of JAK inhibitors.

Join Professor Janet Pope and Dr Sofia Ramiro on The IMID Forum as they discuss the long-term safety of JAK inhibitors in RA. They delve into papers comparing tofacitinib versus TNFi in cardiovascular risk and the efficacy of upadacitinib over five years. The podcast also explores the importance of proper treatment to reduce risks and the balancing act of benefits versus risks in JAK inhibitor prescriptions for inflammatory diseases.